Aminaphtone for Light Bleeding in Patients Under Oral Anticoagulation
José Maria Pereira de Godoy1, *, Gustavo Paludetto2, Bianca R Testoni2, Priscilla Yukiko Sano2
Identifiers and Pagination:Year: 2010
First Page: 146
Last Page: 147
Publisher ID: TOCMJ-4-146
Article History:Received Date: 6/5/2010
Revision Received Date: 13/5/2010
Acceptance Date: 18/5/2010
Electronic publication date: 18/6/2010
Collection year: 2010
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Bleeding is a common complication of oral anticoagulation therapy.
The present study evaluated the use of aminaphtone in patients with minor bleeding while taking warfarin.
Seven patients suffering from bleeding of the nose and gums, who were taking therapeutic doses of warfarin, were included in the study.
The patients were prescribed 75 mg aminaphtone twice daily. For 5 of these patients the bleeding was controlled within 48 h, for 1, within 96 h and for the other, a satisfactory reduction was obtained.
Patients with minor bleeding during treatment using oral anticoagulation, who are free from risk of other complications, can benefit from the use of aminaphtone as an initial therapeutic option.